Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05119023 · ClinicalTrials.gov registry record · NA

Determining Learning Ability in People With Aphasia

A NA study, sponsored by MGH Institute of Health Professions.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT05119023 is a NA study that has completed, run by MGH Institute of Health Professions. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05119023, a NA study, has completed, sponsored by MGH Institute of Health Professions.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

Aphasia is an impairment in the expression or comprehension of language that results from stroke, traumatic brain injury or progressive neurological disease. Approximately two million people in the United States suffer from aphasia, which has profound impacts on quality of life, the ability to return to work and participation in life activities. Research has shown that speech-language therapy, the treatment for aphasia, can significantly improve people's ability to communicate. However, a major limitation in the field of aphasia rehabilitation is the lack of predictability in patients' response to therapy and the inability to tailor treatment to individuals. Currently, aphasia treatments are selected largely based on patient's language abilities and language deficits with little consideration of learning ability, which this study refers to as learning phenotype. Learning phenotype has been used to inform rehabilitation approaches in other domains but is not currently considered in aphasia. The overarching hypothesis of this work is that poor alignment of learning ability and language therapy limits progress for patients and presents a barrier to individualizing treatment. The objectives of the proposed study are to (1) determine the learning phenotype of individuals with aphasia, and (2) examine how lesion characteristics (size and location of damage to the brain), language ability and cognitive ability relate to learning ability. To accomplish objectives, investigators propose to measure implicit (observational) and explicit (rule-based) learning ability in people with aphasia via computer-based tasks. Regression models will be used to examine brain and behavioral factors that relate to learning ability.

Interventions

  • OTHER Brain imaging
  • BEHAVIORAL SRT Observational Learning
  • BEHAVIORAL AGL Observational Learning
  • BEHAVIORAL AGL Rule-based Learning
  • BEHAVIORAL Standardized cognitive-linguistic assessment

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-06-06
Est. Completion 2023-09-01
Phase NA

What the Registry Record Tells You About NCT05119023

The ClinicalTrials.gov registry entry for NCT05119023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MGH Institute of Health Professions, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Brain imaging is the first listed.

NCT05119023 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05119023 about?

NCT05119023 is a clinical study titled "Determining Learning Ability in People With Aphasia". Aphasia is an impairment in the expression or comprehension of language that results from stroke, traumatic brain injury or progressive neurological disease. Approximately two million people in the United States suffer from aphasia, which has profound impacts on quality of life, the ability to retur...

What is the current status of trial NCT05119023?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-06-06. Estimated completion is 2023-09-01.

What interventions are being tested in trial NCT05119023?

The interventions under investigation include: Brain imaging (OTHER), SRT Observational Learning (BEHAVIORAL), AGL Observational Learning (BEHAVIORAL), AGL Rule-based Learning (BEHAVIORAL), Standardized cognitive-linguistic assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05119023?

This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.